Dr. John Cush RheumNow
5 years 8 months ago
Swedish Rheumatology Quality Register study of 46316 RA pts (322601 visits) shows RA has a higher risk of venous thromboembolism (RR 1.88;95% CI 1.65, 2.15) & this increased with disease activity (RR=2.03;1.73 to 2.38) (compared to remission). https://t.co/R59tLy8WGx
Dr. John Cush RheumNow
5 years 8 months ago
Dr. Janet Woodcock has been appointed the interim head of the FDA. President Biden has yet to nominate a new FDA commissioner. Dr. Woodcock is a rheumatologist and current Director of CDER at the FDA .https://t.co/Wk0auZ2pn1
Dr. John Cush RheumNow
5 years 8 months ago
Sign up to attend RheumNow Live--March 20 and 21. CME credits available
https://t.co/vJlU0Z3Q3x https://t.co/Z0ectgFD2d
Dr. John Cush RheumNow
5 years 8 months ago
ACR Convergence 2020 Fireside Chats – top presentations in Still’s disease
Sponsored by Novartis Medical Affairs
Unable to attend all the key sessions at ACR Convergence 2020? Listen to the experts as they present their views on the top abstracts.
https://t.co/MD6lU5oIvy https://t.co/CHRy3yeTwN
The benefits of hydroxychloroquine in lupus are many, but if you were to withdraw HCQ? A recent study of five Canadian cohorts, suggests that certain baseline variables, including age, race, and steroid use, were predictive of flare in patients with SLE who tapered or discontinued treatment with hydroxychloroquine.
Health equity in the telehealth age has assumed added importance since the COVID-19 pandemic began. The Federal Communications Commission estimates that about 21 million Americans don't have access to the Internet in their homes. Other sources estimate it is closer to 162 million. However, the problem extends beyond reliable Internet or access to a smartphone, tablet, or computer.
Dr. John Cush RheumNow
5 years 8 months ago
Pooled analysis of 16 RCTs in 7044 abatacept treated pts (21,274 PYs exposure) found very low risk of opportunistic infections ranging from OIs 0.17 to 0.21 on ABA and 0.56 on placebo - only 13 TB cases; IR for H zoster was low 1.53/100PY https://t.co/kOWYxEmQLd
Dr. John Cush RheumNow
5 years 8 months ago
QD Clinic - Raynaud's or Not
Lessons from the clinic an evaluation of blue fingers
https://t.co/5EOvoM5jVf
Dr. John Cush RheumNow
5 years 8 months ago
Travel During COVID-19 Pandemic--The CDC has addressed the effects and the issues of domestic and international travel on its website.
Read the full article for more information.
https://t.co/wtn5dV6swM https://t.co/0HdC5CfUop
Dr. John Cush RheumNow
5 years 8 months ago
44 pts of Inclusion body myositis were randomized to either PBO or sirolimus 2 mg/d. At 12 mos there were no signif differences betw groups for motor strength , but sirolimus had more SAEs (45 vs 27%); yet sirolimus had better HAQ, FVC & 6-min walk times. https://t.co/YhnRTnaGFl
Dr. John Cush RheumNow
5 years 8 months ago
The NEJM has featured an overview of Osteoarthritis of the Knee. https://t.co/1AaNICygOr
Dr. John Cush RheumNow
5 years 8 months ago
Belated congratulations to Dr. David T. Felson, for receiving the Lee C. Howley, Sr. Prize for Arthritis Science from the Arthritis Foundation. He is a professor of medicine and epidemiology at Boston University's Schools of Medicine and Public Health https://t.co/U7yKnWWLxc
The CDC has addressed the effects and the issues of domestic and international travel on its website. Below is a sampling of key advice.
Dr. John Cush RheumNow
5 years 8 months ago
ACR Convergence 2020 Fireside Chats- top presentations in nr-axSpA, AS, axial PsA and Still’s disease.
Sponsored by Novartis Medical Affairs
Unable to attend the key sessions at #ACR20? Listen to the experts as they weigh in on the top abstracts.
https://t.co/cUj5T3reyG
Dr. John Cush RheumNow
5 years 8 months ago
New QD Clinic—This week’s videos: Clinic Emergencies, Stopping Meds, 3 Issues After COVID Vaccination, My New Clinic COVID Routine, Raynaud's or Not
https://t.co/R0zcRq6Sg1
